TBI, ADwTBI, and AD cases all show substantial astrogliosis (increased GFAP immunoreactivity) and microgliosis (increased IBA-1 immunoreactivity) compared with controls (Fig. 3a–c). This evidence concerns the gene GFAP and Alzheimer disease.